Physician

Mark Workman, M.D.

According to 2025 Medicare claims, Mark Workman, M.D. (NPI: 1447238415) practices pain management in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is THE PAIN REHABILITATION GROUP OF WICHITA FALLS P.A. (NPI: 1609892074; TIN: 752730660) and primary practice location at 76308-3879. Workman is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Workman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 882 traditional Medicare patients, billed 4,207 HCPCS/CPT codes, and received $308,755 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 8,942 prescription claims across 989 beneficiaries totaling $632,482 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 23 records totaling $417. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $484,871 to $308,755. Similarly, Part D prescription costs have declined steadily, from $1,423,153 to $632,482. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,316	9,064	$484,871
2016	1,350	9,617	$554,028
2017	1,279	9,095	$534,197
2018	1,187	7,969	$454,323
2019	1,131	7,352	$460,297
2020	1,071	6,534	$381,896
2021	990	6,071	$429,660
2022	894	5,072	$344,525
2023	849	4,510	$312,433
2024	882	4,207	$308,755

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	911	11,917	$1,423,153
2016	919	12,263	$1,394,794
2017	877	11,547	$1,209,541
2018	861	11,204	$1,124,571
2019	873	10,980	$962,292
2020	853	11,858	$913,404
2021	853	10,306	$811,565
2022	848	9,298	$750,540
2023	900	9,114	$715,959
2024	989	8,942	$632,482

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	91	91	$122
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	104	128	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	403	642	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	700	2,287	$58
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	91	120	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	2,583	74,741	$79,515
Nucynta Er	Tapentadol Hcl	52	1,485	$78,086
Oxycontin	Oxycodone Hcl	100	2,852	$76,565
Buprenorphine	Buprenorphine	202	5,656	$55,662
Fentanyl	Fentanyl	321	9,443	$43,984

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$417	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Workman, M.D.?

Tedicare shows public-source Medicare data for Mark Workman, M.D. (NPI 1447238415), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Workman, M.D. have ACO affiliation data?

Mark Workman, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mark Workman, M.D.?

Mark Workman, M.D. is linked to THE PAIN REHABILITATION GROUP OF WICHITA FALLS P.A. (billing NPI 1609892074) in the available physician profile data.

Does Mark Workman, M.D. have Open Payments data?

Mark Workman, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.